<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is usually defined by the association of clinical manifestations that comprise venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, recurrent fetal losses, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, along with the presence of anticardiolipin (aCL) antibodies and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Various <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, in which these antibodies need the presence of beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I </plain></SENT>
<SENT sid="2" pm="."><plain>Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and 100 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical events of APS, the level of beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>Positive results for aCL antibodies were found more frequently (3 </plain></SENT>
<SENT sid="5" pm="."><plain>3%) for the patients with HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> than for healthy controls (0%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> positive aCL antibodies were beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I independent </plain></SENT>
<SENT sid="7" pm="."><plain>No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed </plain></SENT>
<SENT sid="9" pm="."><plain>As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients </plain></SENT>
</text></document>